Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTHI
NTHI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTHI News
Emerging Biotech Firms Show Significant Clinical Progress
Jul 01 2026
Newsfilter
Significant Transformation in Cancer Treatment
Jun 25 2026
Newsfilter
Significant Transformation in Cancer Treatment
Jun 25 2026
Globenewswire
NeOnc Technologies Secures Major Clinical Approval for NEO100 Program
Jun 23 2026
Globenewswire
NeOnc Technologies Secures Drug Authorization, Market Focuses on Clinical Progress
Jun 23 2026
Newsfilter
NeOnc Secures Abu Dhabi IND Authorization for NEO212
Jun 22 2026
Globenewswire
NeOnc Secures Abu Dhabi IND Authorization for NEO212
Jun 22 2026
Newsfilter
NeOnc Technologies Secures International Drug Authorization for NEO212
Jun 17 2026
Newsfilter
NeOnc Technologies Secures Key International Regulatory Milestone
Jun 17 2026
Globenewswire
NeOnc Technologies Secures IND Approval, Advancing Neuro-Oncology Innovations
Jun 17 2026
Newsfilter
CervoMed and Others See Significant Stock Gains
Jun 17 2026
NASDAQ.COM
Biotech and AI Companies Capture Investor Attention
Jun 16 2026
Globenewswire
Emerging Companies in Biotech and AI Gain Attention
Jun 16 2026
Newsfilter
NeOnc Technologies Secures IND Approval for NEO212 in Neuro-Oncology
Jun 16 2026
Newsfilter
Biotech Companies Achieve Significant Milestones
Jun 16 2026
Globenewswire
Biotech Companies Achieve Significant Milestones
Jun 16 2026
Newsfilter
Show More News
